Cumberland Pharmaceuticals Inc

Research Cumberland Pharmaceuticals Inc (CPIX) on Bullrun: market cap USD 102.48M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCPIX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 102.48M
• Financial periodFY2025
• RevenueUSD 44.52M
• Revenue growth17.6%
• Net income-USD 2.84M
• Free cash flowUSD 4.83M
• Gross margin85.0%

Valuation Snapshot

latest market cap is USD 102.48M.

About Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment;

Frequently asked questions

What is Cumberland Pharmaceuticals Inc's market cap?

Cumberland Pharmaceuticals Inc's market capitalization is USD 102.48M.

What does Cumberland Pharmaceuticals Inc do?

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning;